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Dr. Alan Robertson 
 
A Review of Therapeutic Drugs Used for Doping of Race 
Horses: NSAIDs, Acepromazine, and Furosemide 
 
Abstract 
 Doping in the horse racing industry has been a problem ever since it began. Different 
drugs are used to increase the chance of winning, losing, and even masking the use of other 
drugs. Some drugs are used only to enhance performance, but there are also some that are used 
therapeutically that have the capability to alter the performance of the horse. The three drugs that 
will be discussed in this review are NSAIDs, Furosemide, and Acepromazine. NSAIDs are used 
to control pain and inflammation, but in doing so can allow the horse to run at full capacity even 
if there is an underlying injury such as a sprain. Furosemide is a diuretic that therapeutically is 
used to decrease the chance of developing exercise-induced pulmonary hemorrhage, but can also 
mask the use of performance enhancing drugs. Finally, acepromazine is a sedative that can be 
used to calm a horse who is overly excitable but can also be used to decrease the performance of 
a horse in order to alter the winner and can have an impact on those that are betting. The 
pharmacology of these three drugs will be further explored into how they exert their effect and 








 The horse racing industry is 
a billion dollar industry with more 
than 1.2 million horses used for 
racing (AHCF, 2017). In the 
United States, the most significant 
racing event is the Kentucky Derby 
held in Louisville, Kentucky on the 
first weekend of May each year. 
The winnings from the race total 
$2 million. On the side, there are 
also bets placed that can surpass 
$200 million and that only includes 
the legal bets that were placed 
throughout the day. With so much on the line, it is no surprise that drugs would be used illegally 
to increase the chances of a horse winning or losing (Tuttle, 2018).  
The most apparent use of drugs given on race day involve those for doping to win. This 
method is characterized by improving the overall physiologic capacities of the horse. The drugs 
that are most used include NSAIDs, steroids, and bronchodilators. The other option for drug use 
involves doping to lose where the ability of the horse is impaired in some way. The most 
common drugs for this category are sedatives or tranquilizers. Another important use of drugs is 
known as doping to mask which involves using masking agents that will hide the use of other 
drugs. These drugs are diuretics such as furosemide, and this makes the use of illegal drugs 
harder to detect. The final classification is inadvertent doping which is characterized by being 
unaware of the side effects of combining drugs or supplements and how long those effects would 
ensue (Ungemach, 1985). However, this is a smaller category and with proper care and drug 
administration can be avoided. Therefore this categorization will not be examined further. 
Most drugs are not allowed in any quantity on race day in order to try to combat the 
doping of horses. Therapeutic drug classes are a bit harder to control since they have a function 
that can aid in the horses' overall health. To try to control the overuse of these drugs and to 
Figure 1: Justify #7 was the winner of the 144th Kentucky Derby 
held at Churchill Downs on May 5th, 2018 in Louisville, Kentucky. 






decrease the potential for doping, officials have tried to establish a policy in the United States 
which has legalized certain drugs and created limits on the administration of those drugs. The 
way in which these drugs are categorized is known as the Uniform Classification of Foreign 
Substances and was created by the Association of Racing Commissioners International (RCI). 
This group gets together to review the policies on a semi-annual basis to keep up with changing 
drug availability and ever growing knowledge on the drugs. There are four classes of drugs 
which range from Class 1 to Class 5. Class 1 drugs do not have a therapeutic use that is 
acceptable to the racing industry because the performance enhancing effect is extremely high. 
These drugs are characterized as stimulants or depressants and are typically opioids or 
amphetamines. Class 2 drugs are also unacceptable for therapeutic use due to their high 
performance enhancing ability. These drugs focus on cardiovascular and nervous system 
stimulants and neuromuscular blockers. Caffeine is an example of a drug from this class. The 
drugs that will be focused on in this review are categorized as Class 3 and Class 4 drugs. 
Although there is therapeutic use there is also a moderate ability for the Class 3 drugs to have the 
capability to enhance performance while the Class 4 drugs have a moderate to high effect. 
Winstrol is an example of a Class 3 drug and phenylbutazone is a Class 4 drug. The final 
categorization is Class 5 drugs which are allowed but have specific concentration limit 
requirements. There is potential to have performance enhancing capabilities but with controlled 
dosage this is lessened. Class 5 drugs have a localized action and an example is ranitidine (Allin, 
“Part 4”). 
In the subsequent sections several of the drugs used for doping to win, lose, and mask 
will be examined. The pharmacology, effects, and detrimental use of each will be assessed. The 
possible testing methods and the allowed concentrations of several drugs will also be explored. 
Finally, the concerns for the future will be addressed and will focus on the continual use and 







Doping to Win 
 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are possibly the most used class of 
medications in equine medicine for the alleviation of pain and inflammation of the 
musculoskeletal system (Kynch et al., 2018). Phenylbutazone is an example of an NSAID that is 
used to treat sprains, strains, muscular overuse, and tendonitis (Allin, “Part 7”). Being a Class 4 
drug there is a beneficial therapeutic use that causes increased use of the drug. In 2010 the 
United States Equestrian Federation created a new rule that only allows the use of one NSAID 
during races. This rule came about because of a practice known as "stacking." The previous rule 
allowed two NSAIDs to be used as long as phenylbutazone and flunixin were not used together 
(Sweeney, 2010). Phenylbutazone is commonly administered intravenous but is not allowed 24 
hours pre-race (Racing Medication and Testing Consortium [RMTC], 2016). The pharmacology 
of how these drugs act will be explored next. 
 Pharmacology 
There is little evidence that NSAIDs on their own lead to enhanced performance. Instead, 
it masks the pain and increases mobility through the inhibition of cyclooxygenase enzymes 
known as COX 1 and COX 2 (Kynch et al., 2018). COX 1 enzymes are expressed in most tissues 
(Rang et al., 2016) including the gastrointestinal tract while COX 2 enzymes are found around 
sites of inflammation (Hawkey, 2001). Typically after tissue injury, arachidonic acid is oxidized 
by these COX enzymes and leads to the production of eicosanoids, specifically prostaglandins. 
By inhibiting cyclooxygenase, the oxidation of arachidonic acid is prevented and leads to 
decreased production of eicosanoid. These inflammatory mediators include prostaglandins, 
leukotrienes, and thromboxane A2. All play an essential role in the inflammatory cascade and 




The COX 1 enzyme is constitutional and produces prostaglandins that protect the mucosa 
of the stomach, aid in aggregation of platelets, and plays a role in blood flow through the kidney.  
The inhibition of these actions 
occur quickly and are 
reversible. The COX 2 
enzymes are inducible and 
produce prostaglandins that 
recruit inflammatory cells to 
sites of inflammation. COX 2 
inhibition is irreversible. 
Many NSAIDs are non-
selective and inhibit both 
COX 1 and COX 2 enzymes. 
This is not always ideal as 
COX 1 is responsible for homeostatic functions. Some non-selective NSAIDs that are used in 
equine include phenylbutazone and flunixin (Rang et al., 2016). However, some NSAIDs are 
selective only for COX 2 inhibition and focus solely on reducing pain and inflammation. 
Firocoxib and meloxicam are both examples of COX 2 selective inhibitions that are used in 
equine (Walden, 2017). 
Detrimental Use 
 Short term NSAID use itself does not produce many side effects as compared to chronic 
use. However, a common practice that is has been known to be used in the horse racing industry 
is known as “stacking” NSAIDs. Stacking NSAIDs refers to the practice of administering two 
different drugs from the same class at the same time. The conventional NSAIDs of choice are 
flunixin and phenylbutazone although the use of both of these drugs at the same time is currently 
illegal in the horse racing industry. There is little research that provides evidence of any positive 
effects of combining the abilities of two NSAIDs. Some speculate that the use of two together 
will create an even more significant benefit than if only one was administered. There are others 
who believe that stacking does not produce that effect and can actually increase unwanted side 
effects. One study was performed that used thirteen horses split into two groups to determine the 
Figure 2: COX 1 and COX 2 Mechanisms of Action. Image 
Obtained from Hayat, 2013. 
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effects of one NSAID compared to two administered at one time. The first group of horses were 
given phenylbutazone and flunixin together and then after some time was given only 
phenylbutazone while the second group had the opposite treatment. Blood samples were 
collected on the first and last days of administration, and the protein levels were examined. The 
reason protein levels were read was due to the fact that when the gastrointestinal tract is damaged 
protein concentrations are severely decreased. For the second group that was only given 
phenylbutazone first, there were insufficient changes in the protein levels but after both drugs 
had been administered the protein levels dropped dramatically. These results led the researchers 
to believe that by using more than one NSAID at a time, the gastrointestinal tract was severely 
damaged. There was even one horse that died from NSAID toxicity (Equus, 2006). 
 Not only are NSAIDs used during race time, but they are also used before when the 
horses are preparing for races. Another issue with continual and repeated use of NSAIDs in 
racehorses is that over time the horse will develop a tolerance to the drugs. The effectiveness of 
these drug will begin to decrease, and a larger dose will be required to obtain the same effect as 
was initially seen (Allin, “Part 7”). A common NSAID used is phenylbutazone which can 
increase the risk of gastrointestinal ulcers when administered on a continual basis or increased 
dose. Ulcers are a common ailment of horses, but there is an increased risk in racehorses due to 
the overuse, high-intensity exercising, and also stress (Allin, “Part 4”). 
 
Doping to Lose 
 Acepromazine is a common sedative in the horse industry used for the calming and 
tranquilizing effects that it produces. Many people may not think of this type of drug being used 
in horse racing, but it can be used to decrease the performance of a high profile horse that is 
pegged to do well. The appeal of this is that people will bet on the horse that is expected to do 
well and will lose those bets while there may be a select few who bet against that horse and then 
win those earnings (PubChem CID: 6077, n.d). Acepromazine, commonly referred to as Ace, is 






 Acepromazine is a phenothiazine derivative which causes antiemetic properties to be 
exerted on the central nervous system (PubChem CID: 6077, n.d). Although the complete 
mechanism of action is not well understood, because it is classed in the phenothiazine group of 
drugs, it is thought to affect in large part the dopaminergic receptors (Kynch et al., 2017). It is 
also believed to act as an antagonist on not only dopamine but also serotonin, histamine, alpha-1, 
alpha-2, and muscarinic receptors (PubChem CID: 6077, n.d). Phenothiazines act specifically on 
D2 dopaminergic receptors to act as a sedative and tranquilizer. Dopamine receptors are known 
as G-protein coupled receptors and act as first messengers through their interaction at 
postsynaptic membranes. Through these interactions transduction of G-proteins occurs at the 
necessary intracellular effector system (Riviere and Papich, 2009). 
 After intravenous injection, acepromazine is eliminated quickly due to the rapid 
metabolism of its metabolites, 2-(1-hydroxyethyl) promazine (HEP) and 2-(1-hydroxyethyl) 
promazine sulfoxide (HEPS). A study published in the Journal of Veterinary Pharmacology and 
Therapeutics was performed on thoroughbred horses to determine the metabolism of 
acepromazine intravenously. Fifteen total horses were used and for the intravenous injection two 
catheters were placed in the external jugular veins. One of the catheters was used for 
administration of the drug while the other was used for retrieval of blood samples. A blood 
sample was collected prior to administration of the drug. A single dose of 0.09 mg/kg of 
acepromazine was administered to each horse. The next sample collections began after five 
minutes and continued in intervals all the way up to 72 hours post injection. During analysis of 
the blood samples, the collection tubes sat at room temperature for at least twenty minutes and 
then were centrifuged to obtain a serum sample (Kynch et al, 2017). 
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The serum was 
analyzed using a 











with turbulent flow 
chromatography was also used for quantitative analysis of the serum. 85% of acepromazine, 80% 
of HEP, and 100% of HEPS was recovered in the serum. The concentrations of the acepromazine 
and its metabolites are characterized in Figure 3 (Kynch et al, 2017). 
Detrimental Use 
 If administered in too high of a dose, acepromazine toxicity effects can be severe. Some 
of these symptoms include convulsions, difficulty breathing, irregular heart rate, and low blood 
pressure (PubChem CID: 6077, n.d). By impacting dopamine receptors, high levels can cause 
extrapyramidal signs that include restlessness, rigidity, and tremors. There are also effects on the 
hypothalamus that alter the ability to regulate their temperature leading to a decrease in body 
temperature and possibly hypothermia. Acepromazine is also an alpha-1 adrenergic blocker and 
therefore causes vasodilation, a decrease in blood pressure, and even tachycardia if severe 
enough. Another cardiovascular problem that can occur is decreased hematocrit levels caused by 
the accumulation of red blood cells in the liver and spleen (Pawson, 2008). Interactions with 
other drugs can lead to some of the severe side effects and may cause prolonged central nervous 
system depression (Riviere and Papich, 2009). 
 
Figure 3: Concentration of acepromazine and metabolites in the serum 
over time. Image obtained from Kynch et al., 2017.  
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Doping to Mask 
Furosemide is a common Loop diuretic that is responsible for increasing urine output. 
This drug has a fast onset and short duration of action. From these actions, it is important in 
horse racing because it allows for a decreased chance of detecting other drugs that may be in the 
horse's system because it does increase urine output thus increasing the excretion of other drugs 
that were administered to the horse (Hinchcliff and Muir, 1991). Some drugs that furosemide 
masks include corticosteroids, NSAIDs, albuterol, and opioids. Since furosemide acts by 
increasing the output of urine, any drug that is primarily excreted in the urine can be masked 
(ARCI, 2017). 
The therapeutic use of furosemide and the reason it is allowed to be administered four 
hours before race time is for decreasing the risk of exercise-induced pulmonary hemorrhage 
although the mechanism for this is unknown (Hinchcliff and Muir, 1991). Exercise-induced 
pulmonary hemorrhage causes bleeding in the lungs and nasal canal during high-intensity 
exercise. (Gershman, 2018). When horses run at high intensities the volume and pressure of 
blood and air increases dramatically during inspiration and expiration and can cause the blood-
gas barrier of the alveolus to rupture. This results in blood entering the lungs and is thought to 
occur in at least a small degree in most racehorses. Repeated bleeding in the lungs causes 
permanent damage and can in some cases be fatal. The use of furosemide is thought to decrease 
the number of incidences by decreasing fluid buildup, increasing urine production, and 
decreasing hydrostatic pressure. The increase in urine output can also allow the horse to lose 










What is known about the mechanism of action of furosemide is that it has a direct action 
on renal tubular function through the inhibition of sodium and chloride reabsorption in the 
ascending limb of the Loop of Henle. Inhibition of both sodium and chloride is controlled at the 
Na:K:Cl cotransporter found on the luminal surface. By binding and inhibiting at the chloride 
site on the cotransporter, there is an increase of sodium and chloride delivery to the distal tubule. 
This leads to an increase in the production of a large amount of isotonic urine, otherwise known 
as when the urine has equal osmotic concentrations. Aspects that can alter the diuretic response 
includes changes in the plasma protein 
binding, renal blood flow, and plasma 
furosemide concentration (Hinchcliff and 
Muir, 1991). When the transport of sodium 
from the lumen of the Loop of Henle to the 
basolateral interstitium is inhibited, the 
lumen becomes more hypertonic and the 
interstitium less hypertonic. These effects 
significantly reduce the osmotic gradient that 
allows for water reabsorption in the nephron 
(PubChem CID: 3440, n.d). 
 
Although the exact mechanism of action is unknown, it is believed that furosemide 
prevents exercise induced pulmonary hemorrhage through several actions. It functions by 
increasing the rate of urinary sodium, chloride, and hydrogen ion excretion, and decreases 
potassium plasma concentrations. Renal blood flow and venous compliance are increased while 
right atrial pressure, pulmonary artery pressure, pulmonary artery wedge pressure, and 
pulmonary blood volume decrease. Effects of furosemide are modified by administration of 
NSAIDs before furosemide administration. Furosemide reduces the exercise-induced increases in 
right atrial, aortic and pulmonary artery pressures (Hinchcliff and Muir, 1991). Since furosemide 
is a potent diuretic, it only takes about four hours to move through the system which is a quick 
metabolism compared to most other drugs (RMTC, 2016)  
Figure 4: Mechanism of Action of Furosemide. 




 Although therapeutic use of furosemide is used to aid in the overall wellbeing of the 
horse, it can also have some unwanted side effects. The diuretic effects can lead to dehydration, 
blood volume reduction, and loss of electrolytes. (PubChem CID: 3440, n.d). These symptoms 
can leave the horse susceptible to muscle weakness and failure which in turn can lead the horse 
to collapse. Collapse can lead to other injuries which can lead to death in a horse (Hickok, 2018). 
The overuse of furosemide has mild effects such as nausea, vomiting, and diarrhea, but more 
severe effects can come from taking other drugs along with furosemide (PubChem CID: 3440, 
n.d). In order to combat the detrimental effects of furosemide, it has been proposed that we focus 
on genetics to remove the trait for bleeding from the gene pool. Nasal strips have also been 
examined as another option for replacement of furosemide use (Hickok, 2018). 
  
Testing 
Several different testing techniques are available in the United States. There is currently 
no standard of testing in the horse racing industry, so many of these techniques are performed 
based on what drugs are being tested for as well as the availability of equipment in the area of 
the races. Below are two techniques that are the most commonly used based on efficiency, 
accessibility, and time. 
Liquid chromatography-tandem mass spectrometry (LC-MS-MS) can test for nineteen 
different drug classes using equine plasma. This process uses on-line solid-phase extraction 
(SPE) along with triple quadrupole mass spectrometry. After the plasma is obtained from the 
horses, the samples are protein precipitated using acetonitrile. The supernatant formed after 
centrifugation is then injected into the on-line SPE system and analyzed through the triple 
quadrupole LC-MS-MS. This technique allows for a short turn-around at less than ten minutes. 
Of the nineteen identifiable drugs bronchodilators, corticosteroids, and sedatives are able to be 
detected to parts per billion (ppb) level. Due to the time, efficiency, and availability this test is 
performed fairly regularly with equine plasma for pre-race screenings (Kwok et al., 2010) 
Another technique for testing for drugs in racehorses is the non-isotopic immunoassay 
which utilizes the particle concentration fluorescence immunoassay (PCFIA) and the enzyme-
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linked immunosorbent assay (ELISA). These tests are fast, inexpensive, and effective. When 
ELISA testing was first performed, several drugs were detected that had previously gone 
undetected. Unlike the thin layer chromatography based testing, the ELISA testing did not have a 
substantial rate of false negative results. A couple of medications that are individually tested for 
include acepromazine, phenylbutazone, and furosemide. The non-isotopic immunoassays can test 
the most potent of drugs, is adaptable to which drugs are being tested, and can be performed 
before and after racing. Both of these tests are also available to test the jockeys and other 
personnel on the racetrack (Tobin et al., 1988). 
There are other tests available besides the two listed above. These can include tests that 
use urine, plasma, serum, saliva, or hair for detection and analysis of drugs. Although the time, 
efficiency, and availability are the main reasons these two tests are used most often, it is also 
possible to choose a test based on which drugs are being screened. It may also depend on 
whether the samples will be collected pre-race or post-race (Tobin et al., 1988).  
In regards to the concentrations of drugs allowed in the serum or plasma this depends on 
the drug itself. According to the 
Reformed Racing Medication 
Rules provided by The Jockey 
Club “no horse participating in a 
race shall carry in its body any 
medications, analogues, or 
metabolites thereof except as 
provided”. Several NSAIDs listed 
include phenylbutazone, flunixin, 
ketoprofen, and methocarbamol. 
Those concentrations that are 
allowed per one milliliter of 
serum or plasma are as follows: 
one microgram of phenylbutazone, 
five nanograms of flunixin, one nanogram of ketoprofen, and one nanogram of methocarbamol. 
Figure 5: Phenylbutazone withdrawal period. Image 
obtained from Meucci et al, 2015. 
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These concentrations are during blood collection post-race. Phenylbutazone, flunixin, and 
ketoprofen are also not allowed to be administered within 48 hours of the post-race time.  
Some drugs including butorphanol, fircoxib, and lidocaine are allowed if an exemption 
form is on file. Normally fircoxib is not to be administered any earlier than fourteen days prior to 
post-race. For acepromazine and its metabolites post-race concentrations may not exceed ten 
nanograms of drug per milliliter of serum or plasma. Acepromazine is not to be administered 
four days prior to post-race time. Furosemide has several guidelines for its use. Administration 
has to be four hours prior to post-race and can be no less than 150 milligrams and no greater than 
500 milligrams intravenously. Blood samples collected from the horses will be ran through any 
of the tests examined previously (The Jockey Club, 2012). 
 
Concerns for the Future 
All three drug classes have a therapeutic use which makes it difficult to distinguish 
whether they are being administered reliably or not. A concern is that if the horse owners and 
trainers advocate for complete freedom in use of these drugs, the ability to abuse them will 
increase tremendously which in turn allows for an increase in doping. With the increased use of 
these drugs, other drugs are also able to be increased in usage. Furosemides is currently only able 
to be administered four hours prior to a race, but if this was to change in order to ensure a 
decreased risk of exercise induced pulmonary hemorrhage other drugs would be able to be 
administered closer to race time and could increase or decrease the performance of the horse 
depending on which result is ideal for that owner. The new policy on NSAID "stacking" has 
prevented the use of two NSAIDs at one time, but if this policy was to be overruled, there could 
either be an enhanced performance for the horse or could result in severe health complications. 
An additional problem with the doping of racehorses is that the public is being deceived 
on which horses are likely to win and those that place bets could lose confidence that they can 
make a fair bet. Placing bets can be for the enjoyment of those participating, but it can also be a 
dangerous business matter for others. If those people are being deceived, they could take their 
business elsewhere, or violence could occur. Neither of these options is ideal for those that are 
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responsible for holding the races. These circumstances might be the primary propulsion for 
officials creating and enforcing the policies on drug administration. 
Novel medications will also begin to become a problem as there will not be enough 
research available to determine the usage and administration as it pertains to horses that will be 
in races. These new drugs will be able to slide through the cracks and make their way onto the 
track. For instance, there is a new NSAID known as Grapiprant approved for use in horses that 
could replace the typical NSAIDs and although it has been shown to have lasting effects in the 
blood, it has not been shown to enhance performance in horses as of yet. The details of results 
from one of those studies are provided below. 
NSAIDs are typically used to mask the pain and inflammation associated with lameness 
in performance horses. However, the use of cyclooxygenase enzyme inhibitors can have long-
term effects that adversely affect the body. Grapiprant is a newly approved medication in dogs 
that is a non-cyclooxygenase inhibiting NSAID which has shown to be effective and safe to use 
in veterinary medicine. Grapiprant’s brand name of Galliprant and is classified as a prostaglandin 
E2 receptor antagonist. Grapiprant functions by binding to EP4 receptors and blocking PCE2 
mediated sensitizations of sensory neurons and stimulation of inflammation. Since 
cyclooxygenase is not inhibited, it is thought that homeostatic functions should not be impacted. 
The inhibition of the homeostatic functions which are associated with many of the side effects 
experienced from NSAID use. 
 To determine if the use of Grapiprant is safe and effective in horses, a study was 
conducted using twelve healthy thoroughbred research horses. Both mares and geldings were 
used between the age of two and six years old. The horses were exercised five days a week 
before the study and throughout the duration excluding days where the drug was administered. In 
order to ensure that there was no interference with other medications, the horses were not given 
anything four weeks before the start of the study. On the day of drug administration, the horses 
fasted for twelve hours before and four hours after drug administration. Every morning before 
administration horses was weighed and a 14-gauge catheter was placed in the external jugular for 
sample collection. Then a single oral delivery of 2 mg/kg tablets was suspended in water and 
delivered using a dosing syringe. Both blood and urine samples were obtained for a period that 
spanned 96 hours. Traces of the drug lasted in the serum for 72 hours while they lasted 96 hours 
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in the urine. Overall the drug was well tolerated in horses and will be a good candidate for 
further exploration and usage in the horse (Kynch et al., 2010).  
 
Opinion 
Therapeutic drugs have a distinct advantage to their use that does not have to do with 
doping. However, for this review, the two have a strong correlation that cannot be overlooked. 
Certain standards have been put in place to try and control the use of therapeutic drugs so that 
they are still able to exert their intended effect while decreasing the chance that they can be used 
for performance altering. Over the last several years testing has become more accessible and 
efficient allowing for results quickly after collection. This dramatically reduces the ability to use 
drugs for doping. However without standardized systems put in place for how testing should be 
conducted it is difficult to know which tests are being used and which drugs are not being tested 
for. 
Another point is that some of the drugs listed as performance-enhancing do not enhance 
the performance but allow for the horse to run to their full capacity. On the standpoint of doping 
to win, the drugs are not increasing performance per se. However, a different issue would be that 
they do hide other ailments that might not allow the horse to perform adequately or could further 
injure the horse which would fall under an animal welfare issue. Many owners and trainers are 
going to want to put the race earnings before the welfare of the horse. This is why veterinarians 
are needed to provide protection and morality in making sure that these horses are not subjected 
to the administration of medications on the sole basis of winning.  
 
Conclusion 
 The sport of horse racing is a massive industry that impacts millions of people. With 
prize money and bets being placed there is a lot at stake for performing to the maximum 
capacity. Although there are quite a few precautions such as testing and penalties that have been 
created to try to combat doping of horses, there are unfortunately still ways that this can occur. 
Many of the drugs that would typically be used for doping do not have any other obvious uses, 
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but some drugs have therapeutic uses. This can cause debate within the horse racing industry on 
whether these drugs should be allowed at any capacity. Currently, concentrations of different 
drugs in a horses system is very limited and should not exceed the concentrations set by The 
Jockey Club (The Jockey Club, 2012). Without consistency in testing and restrictions world-
wide, it is going to be difficult to control the use of drugs during races completely. 
 NSAIDs, furosemide, and acepromazine all have therapeutic uses outside of the racing 
industry which makes it difficult to have a strict ban on the use of these drugs based on the 
welfare of the animal. NSAIDs reduce pain and inflammation which leads to an increases in the 
mobility of the horse. Furosemide is used to decrease the risk of exercise induced pulmonary 
hemorrhage which can lead to severe damage to the lungs and even death. Finally, acepromazine 
can cause a stressed and anxious animal to be more relaxed and reduce the amount of cortisol in 
their system. If there were other options made available to replace the use of these drugs or 
restrictions on when an animal is allowed to race it may be easier to exclude all of these drugs 
from competitions, but there are not practices currently in place to replace any of these drugs. 
There are some options available, but many owners and trainers are not willing to replace drugs 
with other forms of treatment that would not have a simple fix to it. 
Overall the regulations surrounding horse racing is few and far between. Until there is a 
real concern for the use of the drugs in the public viewpoint, there is unlikely to be any change. 
The public is contributing to the business aspect of horse racing by buying tickets, souvenirs, and 
placing bets both legal and illegal. As long as the cash flow is still coming in and the horse injury 
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